4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000023
CEO bought 13,500 shares at an average $0.02 ($230)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-10 | Purchase : show line 1 in the form | +500 | $0.02 | $9 | 21,002,123 | D |
| 2019-04-10 | Purchase : show line 2 in the form | +2,000 | $0.02 | $34 | 21,004,123 | D |
| 2019-04-10 | Purchase : show line 3 in the form | +5,000 | $0.02 | $85 | 21,009,123 | D |
| 2019-04-11 | Purchase : show line 4 in the form | +2,000 | $0.02 | $34 | 21,011,123 | D |
| 2019-04-12 | Purchase : show line 5 in the form | +2,000 | $0.02 | $35 | 21,013,123 | D |
| 2019-04-12 | Purchase : show line 6 in the form | +2,000 | $0.02 | $34 | 21,015,123 | D |
| Open-market purchases · 13,500 sh · avg $0.02 · $230 | ||||||
Loading xslF345X03/primary_doc.xml…